In this Issue:
Clonal haematopoiesis and blood cancer risk inferred from blood DNA
Age-related clonal haematopoiesis associated with adverse outcomes
MM and infections
Inflammation, iron and nutritional status in cancer-related anaemia
Carfilzomib, thalidomide, dexamethasone in newly diagnosed MM
GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anaemia
Cyclophosphamide, prednisone, lenalidomide for relapsed/refractory MM
CHOP-bortezomib in relapsed MCL
MRD as outcome predictor for AML in first CR undergoing myeloablative vs. nonmyeloablative HSCT
Please login below to download this issue (PDF)